Menu Search
Equities

Renalytix PLC

RENX:LSE

Renalytix PLC

Actions
Health CareHealth Care Providers
  • Price (GBX)9.25
  • Today's Change-0.25 / -2.63%
  • Shares traded26.10k
  • 1 Year change-89.17%
  • Beta2.0001
Data delayed at least 20 minutes, as of Sep 20 2024 15:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Renalytix PLC fell by 16.65m. Cash Flow from Financing totalled 15.12m or 444.28% of revenues. In addition the company used 32.67m for operations while cash from investing was breakeven.
Cash flow per share-0.399
Price/Cash flow per share--
Book value per share0.1481
Tangible book value per share0.0477
More ▼

Balance sheet in USDView more

Renalytix PLC appears to have little financial risk as the company holds a substantial amount of cash on its books. In fact, 1.57% of the market capitalization can be attributed to its 24.68m and debt could be paid in full if management chose.
Current ratio1.76
Quick ratio1.71
Total debt/total equity0.6584
Total debt/total capital0.397
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.